1 option
Pharmacy Benefit Managers.
- Format:
- Book
- Author/Creator:
- Cline, Pamela S.
- Series:
- Management Science - Theory and Applications Series
- Language:
- English
- Subjects (All):
- Pharmacy management.
- Prescription pricing.
- Physical Description:
- 1 online resource (239 pages)
- Edition:
- 1st ed.
- Place of Publication:
- New York : Nova Science Publishers, Incorporated, 2024.
- Summary:
- This book explores the role and impact of pharmacy benefit managers (PBMs) within the prescription drug market. It examines their key functions, regulatory frameworks, and the economic dynamics that have led to their current market dominance. Initially, PBMs improved the healthcare system by providing transparency and reducing drug costs through competition. However, the consolidation of the market has resulted in three major PBMs controlling 80% of the market, leading to concerns about increased healthcare costs and reduced competition. The book provides an overview of relevant federal and state laws governing PBMs and discusses the implications for patients, healthcare providers, and policymakers. It is intended for professionals and stakeholders in the healthcare sector, as well as policy analysts and regulators. Generated by AI.
- Contents:
- Intro
- Contents
- Preface
- Chapter 1
- The Role of Pharmacy Benefit Managers in Prescription Drug Markets. Part I: Self-Interest or Healthcare?(
- Statement of Miriam Atkins, M.D., Facp, AO Multispecialty Clinic, Augusta Oncology, P.C. President, Community Oncology Alliance
- Statement of Greg Baker, B.S. Pharm, CEO of Affirmed RX
- Statement of Kevin J. Duane Pharm D, Owner Panama Pharmacy
- Statement of Frederick Isasi, J.D., M.P.H. Executive Director, Families USA
- Chapter 2
- The Role of Pharmacy Benefit Managers in Prescription Drug Markets. Part II: Not What the Doctor Ordered(
- Statement of "JC" Scott President and CEO, Pharmaceutical Care Management Association (PCMA)
- Statement of Lori Reilly Chief Operating Officer PhRMA
- Statement of Craig Burton, Executive Director, Biosimilars Council, Senior Vice President, Association for Accessible Medicines
- Statement of Hugh Chancy, RPH President, National Community Pharmacists Association (NCPA)
- Statement of Rena M. Conti Ph.D. Associate Professor Department of Markets Public Policy, and Law Questrom School of Business
- Chapter 3
- Prescription Drugs: Selected States' Regulation of Pharmacy Benefit Managers(
- Why GAO Did This Study
- What GAO Found
- Abbreviations
- Background
- Overview of Private, Employer-Sponsored Health Coverage
- Regulation of Private, Employer Sponsored Health Coverage and PBMs
- Overview of Prescription Drug Spending Trends
- Private Health Plans' Use of PBMs
- Duty of Care Provisions and Fiduciary Duty
- States We Reviewed Have Enacted a Variety of Laws to Regulate PBMs
- Four of Five Selected States Imposed a Duty of Care on PBMs, but States Took Different Approaches
- Selected States' Requirements for PBMs on Drug Pricing and Pharmacy Reimbursement, Transparency, and Access.
- Drug Pricing and Pharmacy Reimbursement Requirements
- Transparency
- Networks and Access
- Stakeholders Expressed Mixed Views on Selected State Actions to Regulate PBMs
- Stakeholder Views on a Duty of Care Requirement for PBMs
- Stakeholder Views on PBM Laws Related to Pricing, Transparency, and Access
- State Regulators Identified Lessons Such as Providing Broad State Regulatory Authority and Robust Enforcement Powers
- Importance of Broad Regulatory Authority
- Robust Enforcement
- Reducing Ambiguous or Fragmented Authority
- Clarity and Precision in Requirements
- Information on PBMs across Different Kinds of Plans
- Agency Comments
- Appendix I: Stakeholders Interviewed by GAO
- Appendix II: Stakeholders Views on Areas of State Pharmacy Benefit Manager (PBM) Regulation in Five Selected States
- Stakeholder Views on PBM Laws Related to Drug Pricing and Pharmacy Reimbursement
- Stakeholder Views on PBM Laws Related to Transparency
- Stakeholder Views on PBM Laws Related to Pharmacy Networks and Access
- Appendix III: GAO Contact and Staff Acknowledgments
- GAO Contact
- Staff Acknowledgments
- Chapter 4
- Pharmacy Benefit Managers: Current Legal Framework(
- Introduction to PBMs
- State Law Regulation of PBMs
- State PBM Regulation and Federal Preemption Challenges
- FTC Action Related to PBMs
- Considerations for Congress
- Disclaimer
- Index
- Blank Page.
- Notes:
- Description based on publisher supplied metadata and other sources.
- Part of the metadata in this record was created by AI, based on the text of the resource.
- ISBN:
- 9798895302255
- OCLC:
- 1467877301
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.